Wu has recently reported that BRD4 can positively regulate EZH2 gene expression through upregulation of c-MYC and that the BRD4/c-MYC/EZH2 axis plays a vital role in the regulation of bladder cancer progression. This evidence concerns the gene EZH2 and urinary bladder cancer.